Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,138 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults

NCT02431767

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
  • Seattle Vaccine and Prevention CRS Seattle, Washington, United States
View Trial Details
Completed

Antigenic Competition in HIV Preventive Vaccines

NCT01159990

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
  • Sao Paulo HVTU - CRT DST/AIDS CRS São Paulo, Brazil
View Trial Details
Completed

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

NCT01783977

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • UIC Project WISH CRS Chicago, Illinois, United States
View Trial Details
Completed

HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants

NCT00125970

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • Miriam Hospital's HVTU Providence, Rhode Island, United States
View Trial Details
Completed

Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults

NCT00486408

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
  • Seattle Vaccine and Prevention CRS Seattle, Washington, United States
View Trial Details
Completed

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

NCT00528489

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • NY Blood Ctr./Union Square CRS New York, United States
View Trial Details
Completed

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

NCT00270218

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • NY Blood Ctr./Union Square CRS New York, United States
  • HIV Prevention & Treatment CRS New York, United States
View Trial Details
Completed

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

NCT00076037

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore Baltimore, Maryland, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
View Trial Details

Related conditions